KBC Group
IDYA icon

KBC Group’s IDEAYA Biosciences IDYA Stock Holding History

KBC Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Hold
3,608
– – ﹤0.01% 1217
2025
Q4 		$125K Buy
3,608
+925
+34% +$29.5K ﹤0.01% 1143
2025
Q3 		$73K Hold
2,683
– – ﹤0.01% 1473
2025
Q2 		$56K Sell
2,683
-1,514
-36% -$29K ﹤0.01% 1555
2025
Q1 		$69K Hold
4,197
– – ﹤0.01% 1684
2024
Q4 		$108K Buy
4,197
+1,923
+85% +$54.4K ﹤0.01% 1501
2024
Q3 		$72K Buy
2,274
+513
+29% +$19.5K ﹤0.01% 1504
2024
Q2 		$62K Buy
1,761
+483
+38% +$19.1K ﹤0.01% 1485
2024
Q1 		$56K Buy
+1,278
New +$55K ﹤0.01% 1484

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

KBC Group's IDYA Position: Q1 2026 in Review

KBC Group held its IDEAYA Biosciences (IDYA) position steady in Q1 2026 at 3,608 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

KBC Group first reported a position in IDYA in Q1 2024 and has held it in 9 quarters since. The position peaked at $125K in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • KBC Group held 3,608 shares of IDEAYA Biosciences worth $120K as of Q1 2026.
  • KBC Group left its IDEAYA Biosciences share count unchanged in Q1 2026.
  • IDEAYA Biosciences made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1217 holding.
  • KBC Group first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 9 quarters since.
  • KBC Group's IDEAYA Biosciences position peaked at $125K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.